Buchanan Ingersoll & Rooney outlines what compounding pharmacies should watch for now that the FDA has sent its interim peptide policy to the White House for review.
Recap by typeshit. Full story at Buchanan Ingersoll & Rooney PC.
A lawyer named Jeff walks through how his side argues Ozempic, Wegovy and other semaglutide drugs may be linked to NAION, a serious form of sudden vision loss.
Stavros Nicolaou of the Pharmaceutical Task Group wants police to act. SAHPRA says it has seized products and opened criminal cases.
The physician group is pushing back on an FDA plan that would open interim access to unapproved peptides, and wants the White House to block it.
Investigators turned up a warehouse of empty pens and a farm building used as a drug factory, as counterfeit weight loss injection sellers grow more organized.
NewsNation reports FDA inspectors found mold at Chinese plants supplying compounded GLP-1 drugs, a fresh safety flag for anyone using cheaper copies.
A personal diary entry built around a protein shake and a fresh mindset. It's light on detail and reads mostly as motivation.
Loading…